Concepedia

Publication | Closed Access

Monoclonal antibody cetuximab binds to and down-regulates constitutively activated epidermal growth factor receptor vIII on the cell surface.

150

Citations

36

References

2007

Year

Dipa Patel, Armin Lahiji, Sheetal Patel, Matthew C. Franklin, Xenia Jimenez, Daniel J. Hicklin, Xiaoqiang Kang
PubMed

Abstract

These data suggest that cetuximab may be a potential candidate for the treatment of tumors that also express EGFRvIII.

References

YearCitations

Page 1